Citations refer to the original publication, not to a Scieee localized version.
Salamero, O., Montesinos, P., Willekens, C., Pérez Simón, J. A., Pigneux, A., Récher, C., & Somervaille, T. C. P. (2020). First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia. American Society of Clinical Oncology. https://doi.org/10.1200/JCO.19.03250
Salamero, Olga, et al. First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia. American Society of Clinical Oncology, 2020. https://doi.org/10.1200/JCO.19.03250.
Salamero, Olga, Pau Montesinos, Christophe Willekens, José Antonio Pérez Simón, Arnaud Pigneux, Christian Récher, and Tim C.P. Somervaille. First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia. American Society of Clinical Oncology, 2020. https://doi.org/10.1200/JCO.19.03250.
Salamero, O. et al. (2020) First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia. American Society of Clinical Oncology. Available at: https://doi.org/10.1200/JCO.19.03250.
O. Salamero et al., “First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia,” American Society of Clinical Oncology, 2020, doi: 10.1200/JCO.19.03250.
@misc{salamero2020firstinhuman,
author = {Salamero, Olga and Montesinos, Pau and Willekens, Christophe and Pérez Simón, José Antonio and Pigneux, Arnaud and Récher, Christian and Somervaille, Tim C.P.},
title = {First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia},
year = {2020},
publisher = {American Society of Clinical Oncology},
doi = {10.1200/JCO.19.03250},
url = {https://doi.org/10.1200/JCO.19.03250}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.
